Navigation Links
DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
Date:8/6/2012

® technology, which is covered by issued patents and pending patent applications owned by us, REMOXY is designed to discourage common methods of tampering associated with prescription opioid analgesic misuse and abuse.
  • POSIDUR(SABER®-Bupivacaine) Post-Operative Pain Relief Depot. Based on recent pre-NDA communications with the FDA regarding POSIDUR, we intend to finish preparing and submit a new drug application (NDA) under 505(b)(2) with the FDA in late 2012 or early 2013.
    POSIDUR is our investigational post-operative pain relief depot that utilizes our patented SABER technology to deliver bupivacaine to provide up to three days of pain relief after surgery.  We currently hold worldwide commercialization rights to POSIDUR.
  • Transdermal Development Candidates.
    DURECT has two transdermal products that are in mid- to late-stage development with features that may be superior to currently available patches.  TRANSDUR-Sufentanil is our proprietary transdermal patch intended to deliver sufentanil to chronic pain sufferers for a period of up to 7 days from a single application; this compares favorably against existing fentanyl patches which are substantially larger and typically effective for 2-3 days.  ELADUR, for topical neuropathic conditions such as post-herpetic neuralgia (PHN), is our proprietary transdermal patch intended to deliver bupivacaine for a period of up to three days from a single application; existing lidocaine patches for this condition can be worn for 12 hours with a rest period of 12 hours during which time many patients experience breakthrough pain.  We are in discussions with potential partners regarding licensing development and commercialization rights to these two transdermal programs to which we hold worldwide rights.
  • ORADUR-ADHD Program.  We are developing a drug candidate (ORADUR-ADHD) based on DURECT's ORAD
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
    2. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
    3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    4. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
    5. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
    6. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
    7. Luminex Corporation Reports First Quarter 2012 Results
    8. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
    9. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
    10. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
    11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 2014 , Industry professionals ... inaugural Tweetchat taking place in real-time at CPhI ... by UBM Live , announces the launch ... first of its kind global industry-wide Tweetchat for ... chain, aimed to stimulate conversations on key industry ...
    (Date:8/28/2014)... YORK, Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: North America Aesthetic ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Outlook to 2020 Summary GlobalData,s new ... Market Outlook to 2020", provides key market data ...
    (Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
    Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
    ... , MORRISTOWN, N.J., Dec. 8 In consultation with the ... has begun a voluntary recall of a single product lot ... Cold Formula Liquid Gels. Bayer initiated the recall after ... certain packages within the lot (less than 4 percent) were ...
    ... , WILMINGTON, Del., Dec. 8 AstraZeneca ... in the company,s Medicare Part D prescription savings program will ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , Prescriptions ... offices under the changes to the AZ&Me(TM) Prescription Savings program ...
    Cached Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2
    (Date:8/30/2014)... OR (PRWEB) August 30, 2014 What ... programs? What are the latest trends, concerns, and considerations? ... and Dr. Ken Pendleton recently spoke with Woody Wommack, ... number of current issues in football recruiting. Notably, ... for younger athletes, changes that he thinks are coming ...
    (Date:8/30/2014)... Saturday 30 August 2014: The first expert ... novel document compiles current evidence on the diagnosis ... by international experts from three continents. , The ... today on-line in EP Europace (1). ... Rhythm Association (EHRA) of the European Society of ...
    (Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The ... oral anticoagulants in pulmonary embolism are published today ... at ESC Congress by Professor Stavros V. Konstantinides ... "2014 ESC Guidelines on the diagnosis and management ... in European Heart Journal (1) and on the ...
    (Date:8/30/2014)... 2014: The therapeutic benefit of revascularisation in coronary ... ESC/EACTS revascularisation guidelines presented at ESC Congress by ... of the European Society of Cardiology (ESC) and ... for Cardio-Thoracic Surgery (EACTS). The joint guidelines are ... (1), on the ESC Website (2), in ...
    (Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 The ... indicates that this new program actually is a system that ... relationships. The program was created by Carrie Engel, who actually ... make sure that users will get the best advices out ... renowned romance guru. , This new program is a ...
    Breaking Medicine News(10 mins):Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3Health News:First expert consensus on ventricular arrhythmias published 2Health News:First expert consensus on ventricular arrhythmias published 3Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 3Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2
    ... is unclear, findings may help improve treatment for psychiatric ... Children with lower IQ have an increased risk of ... problems as adults, a new study that spanned more ... also associated with more persistent depression and anxiety, as ...
    ... implant makes it more difficult to treat the malignancy, ... Women who have had their breasts augmented with implants ... be treated successfully with a partial-breast radiation treatment known ... , "It,s such a challenge to take care of ...
    ... The next time you visit a dentist,in the mid-Michigan ... addition to your brushing habits. , ... Health,Care and the Michigan Primary Care Association are spearheading a ... closely on,detecting high blood pressure in patients. , ...
    ... -- As part of the Dec. 1 observance of ... Pennsylvanians to be tested for HIV - the virus that causes ... the disease and how it is prevented. , ... background, age, ethnicity or race, being tested for HIV is the ...
    ... offers a low cost, non-invasive alternative to conventional ... having coronary artery disease; true even if the ... a study performed at the Thomas Jefferson University ... patients who had one or more calcified coronary ...
    ... molecular breast imaging (MBI) can accurately detect small breast ... a study performed at the Mayo Clinic in Rochester, ... lesions smaller than 2 cm in size were imaged ... confirmed in 88 patients," according to Carrie B. Hruska, ...
    Cached Medicine News:Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 2Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2
    The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
    ... Akers, our ultimate goal is to provide ... and immediate treatment. Each year millions of ... die from late detection or undetected disease ... cripple nations., ,By developing, manufacturing and marketing ...
    ... BD Macro-Vue RPR (Rapid Plasma Reagin) ... Tests are nontreponemal testing procedures for ... in A Manual of Tests for ... manual are the most widely used ...
    Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
    Medicine Products: